This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The growing data infrastructure bubble. Worldwide spending on AI is forecast to reach $2.52 ...
Spire Global has won contracts to provide the National Oceanic and Atmospheric Administration's Commercial Weather Data Program with global navigation satellite system (GNSS) radio occultation and ...
The AI buildout is creating a supply-demand imbalance in storage devices. Prices of DRAM and NAND storage devices soared in 2025. Prices of memory storage devices are expected to continue to climb ...
In 2016 researchers at Bernstein, a broker, published a note entitled “The silent road to serfdom: why passive investing is worse than Marxism”. A decade later the revolution is still in full swing.
To join the CNBC Technology Executive Council, go to cnbccouncils.com/tec Bloom Energy has been around for over two decades and was a startup darling funded by ...
Record valuations and deals driven by AI excitement have led to some concerns that the AI boom is a bubble waiting to burst. Others have argued that the massive investments are necessary to meet data ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Here's a look at some of the ...
There’s a giant question hanging over the tech industry: How long will its massive investments in AI infrastructure really last? Tech giants are shelling out hundreds of billions of dollars on ...
Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
This video explores futuristic concepts for living beyond Earth, including floating bubble habitats and massive zero gravity megastructures. It looks at how humans could survive and thrive in space ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...